RECOFOL 10mg/ml Price

Overview

Welcome to Dwaey, specifically on RECOFOL 10mg/ml Injection/Emulsion for page.
This medicine contains an important and useful components, as it consists of Propofol.
RECOFOL 10mg/ml is available in the market in concentration 10mg/ml and in the form of Injection/Emulsion for .

LEIRAS OY is the producer of RECOFOL 10mg/ml and it is imported from FINLAND, The most popular alternatives of RECOFOL 10mg/ml are listed downward .

Mode Of Action

Short-acting, lipophilic sedative/hypnotic; causes global CNS depression, presumably through agonist actions on GABAa receptors.

Indication

• General anaesthesia
• Sedation

Precaution

Paediatrics, elderly, hypovolaemia, epilepsy, lipid disorders, patients with increased intracranial pressure. Avoid rapid bolus doses in high risk patients. Emulsion formulation of propofol 2% should only be used in children >3 yr. Lactation: Excreted in breast milk; effect on nursing infant not known

Side Effects

• >10% Hypotension (peds 17%; adults 3-26%)
• Apnea lasting 30-60 sec (peds 10%; adults 24%)
• Apnea lasting >60 sec (peds 5%; adults 12%)
• Movement (peds 17%; adults 3-10%)
• Injection site burning/stinging/pain (peds 10%; adults 18%) 1-10% Respiratory acidosis during weaning (3-10%)
• Hypertriglyceridemia (3-10%)
• Hypertension (peds 8%)
• Rash (peds 5%; adults 1-3%)
• Pruritus (1-3%)
• Arrhythmia (1-3%)
• Bradycardia (1-3%)
• Cardiac output decreased (1-3%; concurrent opioid use increases incidence).Tachycardia (1-3%) <1% Arterial hypotension
• Anaphylaxis
• Asystole
• Bronchospasm
• Cardiac arrest
• Seizures
• Opisthotic rxn
• Pancreatitis
• Pulmonary edema
• Phlebitis
• Thrombosis
• Renal tubular toxicity Potentially Fatal: Apnoea
• bradycardia
• hypotension
• convulsions; anaphylaxis.

Contra indication

Electroconvulsive therapy, obstetrics. Sedation in children <16 yr. Pregnancy, lactation.

Pregnancy and lactation

Pregnancy category: B

Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.